Bio-Connect
Human CD26/DPP4 PicoKine ELISA Kit standard curve
Human CD26/DPP4 PicoKine ELISA Kit standard curve
Human CD26/DPP4 PicoKine ELISA Kit standard curve

Human CD26/DPP4 ELISA Kit PicoKine(r)

EK0696
Boster Bio
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human CD26/DPP4 PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    312 pg/ml - 20,000 pg/ml
  • Assay Sensitivity
    <10 pg/ml
  • Assay Time
    20-25
  • Certification
    Research Use Only
  • Scientific Description
    Human CD26/DPP4 ELISA Kit PicoKine® (96 Tests). Quantitate Human DPP4 in cell culture supernatants, serum, plasma (heparin, EDTA) , saliva and urine. Sensitivity: 10pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity Supplier
    Human CD26
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Gulati S, Misra A, Tiwari R, et al. Beneficial effects of premeal almond load on glucose profile on oral glucose tolerance and continuous glucose monitoring: randomized crossover trials in Asian Indians with prediabetes. Eur J Clin Nutr. 2023,77(5):586-595. doi: 10.1038/s41430-023-01263-1
    Read this paper
  • Wang Y, Shao Y, Zhang H, et al. Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy. BMC Genomics. 2022,23(1):630. doi: 10.1186/s12864-022-08854-5
    Read this paper
  • Shao S, Wang C, Tian J, et al. Diagnostic and prognostic significance of serum CD26 level in Asian women with high-grade serous ovarian carcinoma. Future Oncol. 2019,15(16):1863-1871. doi: 10.2217/fon-2018-0725
    Read this paper
  • Enz N, Vliegen G, De Meester I, et al. CD26/DPP4 - a potential biomarker and target for cancer therapy. Pharmacol Ther. 2019,198:135-159. doi: 10.1016/j.pharmthera.2019.02.015
    Read this paper
  • Xinhua W, Xiangting Q, Lingling C, et al. Prognostic Significance of Serum CD26 Concentration in Patients with Esophageal Squamous Cell Carcinoma. Arch Med Res. 2016,47(4):299-303. doi: 10.1016/j.arcmed.2016.07.005
    Read this paper
  • Boccardi V, Marano L, Rossetti RR, et al. Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker. BMC Cancer. 2015,15:703. doi: 10.1186/s12885-015-1757-0
    Read this paper